RUNX1 and breast cancer: To further investigate the role of RUNX1 in regulating breast cancer cell cycle progression, we challenged control and RUNX1-depleted MCF7 cells by treatment with the anti-mitotic taxane drug docetaxel, which normally induces a G2/M block and a mitotic catastrophe51, 52.